Michal Arbel Selected Research

Immunotherapy

12/2007	Immunotherapy for Alzheimer's disease: attacking amyloid-beta from the inside.
9/2007	A novel immunotherapy for Alzheimer's disease: antibodies against the beta-secretase cleavage site of APP.
1/2007	Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michal Arbel Research Topics

Disease

5	Alzheimer Disease (Alzheimer's Disease) 11/2018 - 05/2005
2	Cerebral Hemorrhage 01/2019 - 01/2007
2	Amyloid Plaque 11/2018 - 09/2007
1	Hemorrhage 01/2019
1	Hematoma 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2018
1	Encephalitis (Encephalitis, Rasmussen) 01/2007
1	Neuroinflammatory Diseases 01/2007
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2003

Drug/Important Bio-Agent (IBA)

3	Amyloid beta-PeptidesIBA 12/2007 - 01/2007
3	AntibodiesIBA 09/2007 - 11/2003
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 09/2007 - 05/2005
2	Peptides (Polypeptides)IBA 09/2007 - 11/2003
1	Evans Blue (Blue, Evans)FDA Link 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Dabigatran FDA Link 01/2019
1	Labetalol (Normodyne)FDA LinkGeneric 01/2019
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2019
1	PolymersIBA 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2019
1	Amyloid (Amyloid Fibrils)IBA 11/2018
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	EpitopesIBA 11/2003
1	Prion ProteinsIBA 11/2003
1	AntigensIBA 11/2003

Therapy/Procedure

3	Immunotherapy 12/2007 - 01/2007
1	Therapeutics 11/2003